Business
ALK and GenSci partner to expand the AIT market in China
Inside Information GenSci is granted exclusive rights to ALK’s house dust mite AIT products in China. ALK will be eligible for upfront and milestone payments of up to DKK 1.3 billion in addition to income from supplying GenSci with products.Partnership also aims to accelerate the introduction of a broader portfolio in China.Partnership is projected to become accretive to earnings margin in the medium term but is not expected to materially impact ALK’s revenue and earnings (EBIT) in 2025. ALK (AL
About this update from Alk-abello A/s Class B
[{"type":"image","alt":"ALK Abello","displaySize":"","headline":null,"caption":"ALK Abello","className":"","disableSlideshowImg":false,"size":{"original":{"width":142,"height":39,"url":"https://media.zenfs.com/en/globenewswire.com/a84b59e43cd2eb1b97add5c2b0dfe2b1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/gfL7lNIX7z950ZiB3KRYoQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTU4O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/a84b59e43cd2eb1b97add5c2b0dfe2b1","width":142,"height":39}},"lazy":false},{"type":"text","content":"Inside Information","length":18,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"GenSci is granted exclusive rights to ALK’s house dust mite AIT products in China. ","length":82,"tagName":"p"}]},{"val":[{"type":"text","content":"ALK will be eligible for upfront and milestone payments of up to DKK 1.3 billion in addition to income from supplying GenSci with products.","length":139,"tagName":"p"}]},{"val":[{"type":"text","content":"Partnership also aims to accelerate the introduction of a broader portfolio in China.","length":85,"tagName":"p"}]},{"val":[{"type":"text","content":"Partnership is projected to become accretive to earnings margin in the medium term but is not expected to materially impact ALK’s revenue and earnings (EBIT) in 2025.","length":166,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":472,"olType":false},{"type":"text","content":"ALK (ALKB:DC / OMX: ALK B) today announced a partnership agreement with China-based Changchun GeneScience Pharmaceutical Co. Ltd. (“GenSci”) to develop and commercialise ALK’s house dust mite (“HDM”) allergy immunotherapy (AIT) products in Mainland China.","length":255,"tagName":"p"},{"type":"text","content":"Under the agreement, GenSci is granted exclusive rights to ALK’s injectable Alutard® HDM product, skin prick tests, and the ACARIZAX® SLIT-tablet in Mainland China until the end of 2039. GenSci will incur all costs related to marketing and sales and the majority of costs for the remaining clinical development and registration of the products, while ALK will be responsible for production and supply.","length":401,"tagName":"p"},{"type":"text","content":"GenSci will take over sales and marketing activities of Alutard® immediately and add ACARIZAX® to the portfolio upon regulatory approval of the tablet. ALK and GenSci will co-operate to finalise ...